Interventional techniques for the treatment of structural heart disease are evolving rapidly and have become established routine in a large number of centers worldwide. The most commonly performed percutaneous therapy for valvular heart disease on an urgent basis worldwide is balloon mitral valvuloplasty. Though uncommon today due to infarct vessel recanalization with either primary intervention or thrombolysis post myocardial infarction, ventricular septal defects (VSDs) may, under high-risk circumstances that do not allow conventional surgery, warrant urgent or emergent transcatheter treatment. Progress in transcatheter treatment is rapidly changing the way we tackle structural heart disease. What can be considered an optimal result differs between the various structural diseases and depends highly on the current stage of transcatheter technology, competing surgical and conservative principles, and the individual patient profile.
- Acute structural heart disease
- Aortic balloon valvuloplasty
- Transcatheter treatment
- Valvular heart disease
- Ventricular septal defects (VSDs)